Qiagen NVXTER:QIA -0.72%76 Days Inventory is 151.73 as of Mar. 2026, which is 19% above its 10-year median of 127.27. GuruFocus rates XTER:QIA with a GF Score™ of 76/100 and a GF Value™ of €45.89 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 180 Medical Diagnostics & Research companies, Qiagen NV ranks worse than 76.67% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Qiagen NV's Average Total Inventories for the
three
months ended in Mar. 2026 was €263 Mil. Qiagen NV's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €158 Mil.
Hence, Qiagen NV's Days Inventory for the
three
months ended in Mar. 2026 was 151.73.
The historical rank and industry rank for Qiagen NV's Days Inventory or its related term are showing as below:
XTER:QIA'
s Days Inventory Range Over the Past 10 Years
Min: 101.04 Med: 127.27 Max: 188.67
Current: 134.91
During the past 13 years, Qiagen NV's highest Days Inventory was 188.67. The lowest was 101.04. And the median was 127.27.
XTER:QIA's Days Inventory is ranked worse than 76.67% of 180
companies
in the Medical Diagnostics & Research industry
Industry Median: 64.86
vs XTER:QIA: 134.91
Qiagen NV's Days Inventory
increased
from Mar. 2025 (148.71) to Mar. 2026 (151.73).
It might indicate that Qiagen NV's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Qiagen NV's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.60.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Qiagen NV's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.62.
Qiagen NV (XTER:QIA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Qiagen NV's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Qiagen NV's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Qiagen NV Days Inventory Related Terms
Qiagen NV Days Inventory Historical Data
* Premium members only.
The historical data trend for Qiagen NV's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:QIA vs TWST, CRL, BLLN: Days Inventory Comparison
For the Diagnostics & Research subindustry, Qiagen NV's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qiagen NV Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Days Inventory distribution charts can be found below:
* The bar in red indicates where Qiagen NV's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qiagen NV (XTER:QIA) has a Days Inventory of 151.73 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Qiagen NV and its competitors. This is 19% above median its historical median of 127.27. Over the past decade, Qiagen NV's Days Inventory has ranged from 101.04 to 188.67. According to the industry distribution chart, Qiagen NV ranks #138 out of 180 companies in the Medical Diagnostics & Research industry, placing it in the top 76.7%.
Is Qiagen NV's Days Inventory too high?
Qiagen NV's current Days Inventory of 151.73 is 19% above median its 10-year median of 127.27. Over the past 10 years, this metric has ranged from a low of 101.04 to a high of 188.67. The Medical Diagnostics & Research industry median Days Inventory is 64.86. Qiagen NV's value of 151.73 is 133.9% above this industry median. Based on the distribution chart, Qiagen NV ranks #138 out of 180 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Qiagen NV has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qiagen NV's Days Inventory compare to TWST and CRL?
According to the Medical Diagnostics & Research industry distribution chart, Qiagen NV ranks #138 out of 180 companies for Days Inventory. This places Qiagen NV in the lower half of its industry. The industry median Days Inventory is 64.86. Qiagen NV's value of 151.73 is 133.9% above this benchmark. Historically, Qiagen NV's own Days Inventory has ranged from 101.04 to 188.67 over the past decade. While the company's 10-year median is 127.27 vs. the industry median of 64.86, Qiagen NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 64.86, based on 180 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qiagen NV's current Days Inventory of 151.73 is 133.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Qiagen NV and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 64.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qiagen NV's current Days Inventory is 151.73, which is 19% above median its own 10-year median of 127.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qiagen NV stock overvalued right now?
Based on GuruFocus' analysis, Qiagen NV (XTER:QIA) is currently considered Modestly Undervalued. The stock's GF Value™ is €45.89, compared to a current price of €36.41 — trading 20.7% below its estimated fair value. The current Days Inventory is 151.73, which is 19% above median its 10-year median of 127.27 and 133.9% above the Medical Diagnostics & Research industry median of 64.86. Qiagen NV's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Qiagen NV (XTER:QIA), the current Days Inventory is 151.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qiagen NV (XTER:QIA) Overvalued in 2026?
Based on GuruFocus' analysis, Qiagen NV stock appears to be undervalued.
The current stock price of €36.41 is trading 20.7% below its estimated GF Value™ of €45.89.
GuruFocus considers Qiagen NV to be Modestly Undervalued.
Key valuation signals for XTER:QIA:
Days Inventory: 151.73 (19% above median its 10-year median of 127.27)
GF Value™: €45.89 vs. price of €36.41 (20.7% below fair value)
Industry Position: 133.9% above the Medical Diagnostics & Research median (#138 of 180)
No single metric tells the full story. See the XTER:QIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
76GF Score
Get the complete analysis for XTER:QIA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:QIA has been successfully added to your 
